Insights

Market Leadership EMS holds a dominant position in the Brazilian pharmaceutical market, maintaining the leading market share for nearly two decades and excelling particularly in generics since 2013. This stable leadership suggests strong brand recognition and a wide customer base, presenting opportunities to offer advanced pharmaceutical manufacturing solutions, supply chain enhancements, and premium product development services.

Global Expansion With exports to over 40 countries and manufacturing facilities across Brazil, EMS is actively expanding its international footprint. This global presence creates demand for scalable manufacturing technologies, regulatory consulting, and supply chain integration solutions that support their international growth and streamline their operations in new markets.

Innovation Focus EMS invests heavily in research and development, operating the most modern biotech and pharmaceutical R&D centers in Latin America and collaborating on breakthrough projects like high-complexity generics and biotechnological medicines. This innovation infrastructure offers opportunities to provide cutting-edge research tools, advanced biotech manufacturing equipment, and biotech licensing or partnerships.

Sustainability Commitment The company's engagement in social responsibility initiatives, such as donating medicines to eradicate neglected diseases in partnership with the WHO, highlights its commitment to sustainability and social impact. This focus makes EMS an ideal partner for solutions that enhance sustainability, corporate responsibility, and eco-friendly manufacturing practices within the pharmaceutical industry.

Technology Adoption EMS’s adoption of advanced manufacturing and research technologies positions it as a forward-looking organization. It is receptive to solutions involving digital transformation, smart manufacturing, and automation. Sales opportunities include offering Industry 4.0 tech, integrated ERP systems, and AI-driven analytics to optimize production, compliance, and supply chain management to support their continued focus on innovation and efficiency.

EMS Tech Stack

EMS uses 8 technology products and services including Amazon Web Services, AdOpt, Slick, and more. Explore EMS's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • AdOpt
    Cookie Compliance
  • Slick
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • Imperva
    Security
  • Google Tag Manager
    Tag Management
  • UIKit
    UI Frameworks
  • OpenSSL
    Web Server Extensions

Media & News

EMS's Email Address Formats

EMS uses at least 2 format(s):
EMS Email FormatsExamplePercentage
FLast@emscorporate.comJDoe@emscorporate.com
84%
Last@emscorporate.comDoe@emscorporate.com
9%
First.Last@emscorporate.comJohn.Doe@emscorporate.com
3%
First@emscorporate.comJohn@emscorporate.com
2%
First_Last@emscorporate.comJohn_Doe@emscorporate.com
1%
F.Last@emscorporate.comJ.Doe@emscorporate.com
1%
First.Last@ems.com.brJohn.Doe@ems.com.br
97%
First@ems.com.brJohn@ems.com.br
1%
First.Middle@ems.com.brJohn.Michael@ems.com.br
1%
First_Last@ems.com.brJohn_Doe@ems.com.br
1%

Frequently Asked Questions

Where is EMS's headquarters located?

Minus sign iconPlus sign icon
EMS's main headquarters is located at Rodovia Jorn. Francisco Aguirre Proenca, Hortolandia, SP 13186-525, BR. The company has employees across 6 continents, including South AmericaNorth AmericaEurope.

What is EMS's phone number?

Minus sign iconPlus sign icon
You can contact EMS's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is EMS's stock symbol?

Minus sign iconPlus sign icon
EMS is a publicly traded company; the company's stock symbol is DDD.

What is EMS's official website and social media links?

Minus sign iconPlus sign icon
EMS's official website is ems.com.br and has social profiles on LinkedInCrunchbase.

How much revenue does EMS generate?

Minus sign iconPlus sign icon
As of October 2025, EMS's annual revenue is estimated to be $951M.

What is EMS's NAICS code?

Minus sign iconPlus sign icon
EMS's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does EMS have currently?

Minus sign iconPlus sign icon
As of October 2025, EMS has approximately 13K employees across 6 continents, including South AmericaNorth AmericaEurope. Key team members include Chief Executive Officer: A. A.Chief Executive Officer: B. L.Chief Executive Officer: C. D.. Explore EMS's employee directory with LeadIQ.

What industry does EMS belong to?

Minus sign iconPlus sign icon
EMS operates in the Pharmaceutical Manufacturing industry.

What technology does EMS use?

Minus sign iconPlus sign icon
EMS's tech stack includes Amazon Web ServicesAdOptSlickjQuery MigrateImpervaGoogle Tag ManagerUIKitOpenSSL.

What is EMS's email format?

Minus sign iconPlus sign icon
EMS's email format typically follows the pattern of FLast@emscorporate.com. Find more EMS email formats with LeadIQ.

How much funding has EMS raised to date?

Minus sign iconPlus sign icon
As of October 2025, EMS has raised $91M in funding. The last funding round occurred on Aug 15, 2024 for $91M.

When was EMS founded?

Minus sign iconPlus sign icon
EMS was founded in 1964.
EMS

EMS

Pharmaceutical ManufacturingBrazil10001+ Employees

Fundada há mais de 60 anos e com capital 100% nacional, a EMS é a líder do mercado farmacêutico brasileiro há 19 anos consecutivos, pertencente ao Grupo NC, um dos maiores conglomerados brasileiros.

A empresa ocupa também a liderança no segmento de genéricos desde 2013 (IQVIA 2019) e está entre os maiores laboratórios em preferência prescritiva no Brasil. Tem forte presença em PDVs de todo o país e atuação nas áreas de Prescrição Médica, Genéricos, Marcas, OTC e Hospitalar, fabricando medicamentos para praticamente todas as especialidades da Medicina. Possui fábricas em Hortolândia (SP), Manaus (AM), Brasília (DF) e Jaguariúna (SP).

A EMS apoia ações de responsabilidade social dentro e fora do Brasil. Em 2017, por exemplo, o laboratório fechou parceria com a Organização Mundial da Saúde (OMS) para doar 100% do medicamento para erradicar, nos próximos anos, em todo o planeta, a bouba, doença negligenciada. A EMS é a única farmacêutica no mundo a ter abraçado essa causa.

O Centro de Pesquisa & Desenvolvimento da EMS no Brasil é o mais moderno da América Latina. Na Itália, a EMS tem o laboratório de pesquisas MonteResearch. O foco de atuação do laboratório é a inovação nas seguintes frentes: inovação incremental; genéricos de alta complexidade; medicamentos biotecnológicos, por meio da empresa Bionovis; e inovação disruptiva, por meio da Brace Pharma, empresa da EMS instalada em 2013 nos Estados Unidos.

Ainda, nos EUA, por meio de sua controlada Vero Biotech, localizada em Atlanta, Geórgia, a EMS, recentemente, obteve a aprovação de seu primeiro produto revolucionário submetido à FDA (Food and Drug Administration), posicionando o laboratório como uma empresa de inovação no mercado global.

Com aportes frequentes em infraestrutura fabril e em pesquisa de ponta para desenvolver produtos inovadores, eficazes e seguros, a EMS, que já exporta para mais de 40 países, está preparada para continuar cuidando das pessoas que querem viver cada vez mais e melhor.

Section iconCompany Overview

Headquarters
Rodovia Jorn. Francisco Aguirre Proenca, Hortolandia, SP 13186-525, BR
Phone number
Website
ems.com.br
Stock Symbol
DDD
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1964
Employees
10001+

Section iconFunding & Financials

  • $91M

    EMS has raised a total of $91M of funding over 1 rounds. Their latest funding round was raised on Aug 15, 2024 in the amount of $91M.

  • $10B

    EMS's revenue is estimated to be in the range of $10B

Section iconFunding & Financials

  • $91M

    EMS has raised a total of $91M of funding over 1 rounds. Their latest funding round was raised on Aug 15, 2024 in the amount of $91M.

  • $10B

    EMS's revenue is estimated to be in the range of $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.